<i>CXCR4</i>Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group
H. Matsuo(Kyoto University), Souichi Adachi(Kyoto University), Yasuhiko Kamikubo(Kyoto University), Daisuke Tomizawa(National Center For Child Health and Development), Takashi Taga(Erasmus MC), Akio Tawa(Erasmus MC), Mayu Tokumasu(Kyoto University), Akitoshi Kinoshita(St. Marianna University School of Medicine), Keizo Horibe(National Hospital Organization), Nobutaka Kiyokawa(National Center For Child Health and Development), Yoko Nishinaka‐Arai(Kyoto University), Hiroshi Itoh(Yamaguchi University), Shiro Tanaka(University of Tokyo Health Sciences), Tomohiko Taki(Kyorin University), Akiko Saito(Nagoya University Hospital), Hideki Nakayama(National Hospital Organization Kyushu Cancer Center), Naomi Nakamura(Kyoto University)
Cited by 13
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383